You have read all your free articles, to continue reading subscribe to read the rest of this content.
GSK’s move to a new model of customer engagement has generated a great deal of debate.
Indeed, many commentators remain skeptical that this ‘ethical’ model – especially the decoupling of sales incentives from prescription volume isn’t robust enough to
Related Posts
Tony Hitchcock, Technical Director at Cobra Biologics, a Charles River Company, is joined by Karin Agerman, Chief Research and Development Officer at CombiGene, to explore the effects of the latest regulatory guidelines from both a CDMO and drug development perspective. As the scale and number ofAlready a subscriber Login You…
For six months starting in January 2023 Sweden will hold the Presidency of the Council of the European Union. It is much more than an honorary role, encompassing an opportunity for Sweden to both set new guidelines and see to the implementation of important existing policies. The guiding documentAlready a…
Bluetooth is likely here to stay. And while standard Bluetooth won’t have many GxP applications beyond networking your personal devices, BLE might just find some inroads into GxP, in specific roles that match the capabilities of the technology. I’ve always loved Bluetooth for personal use.ÂAlready a subscriber Login You have…
The Vaisala viewLinc system safeguards valuable reagents, organs and tissues used to save lives.Already a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content.…